XBiotech Inc (NASDAQ: XBIT) stock suffered a major decline of -13.5% on 6/18/24. The shares closed at $5.26. Moreover, this decline was accompanied by exceptionally high trading volume at 904% of normal. The stock has declined -20.7% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
XBIT is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
XBiotech has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. XBiotech has a poor Appreciation Score of 23 but a very high Power Rating of 95, triggering the High Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment